Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-01-14

Clinical Trial Update: Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure [Phase 2]

View source ↗

Summary

Phase 2 placebo-controlled study evaluating safety and ocular efficacy of SBI-100 Ophthalmic Emulsion in patients with elevated eye pressure due to primary open…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SBI-100 Ophthalmic Emulsion

Snippet

Sponsor: Skye Bioscience, Inc. | Conditions: Primary Open Angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2026-01-14